Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial.
Jaun F, Boesing M, Lüthi-Corridori G, Abig K, Makhdoomi A, Bloch N, Lins C, Raess A, Grillmayr V, Haas P, Schuetz P, Gabutti L, Muser J, Leuppi-Taegtmeyer AB, Giezendanner S, Brändle M, Leuppi JD. Jaun F, et al. Among authors: giezendanner s. Trials. 2022 Feb 4;23(1):114. doi: 10.1186/s13063-022-06016-2. Trials. 2022. PMID: 35120577 Free PMC article.
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Boesing M, Abig K, Brändle M, Brutsche M, Burri E, Frye BC, Giezendanner S, Grutters JC, Haas P, Heisler J, Jaun F, Leuppi-Taegtmeyer AB, Lüthi-Corridori G, Müller-Quernheim J, Nüesch R, Pohl W, Rassouli F, Leuppi JD. Boesing M, et al. Among authors: giezendanner s. Trials. 2022 Sep 20;23(1):790. doi: 10.1186/s13063-022-06723-w. Trials. 2022. PMID: 36127739 Free PMC article.
Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial.
Gregoriano C, Dieterle T, Breitenstein AL, Dürr S, Baum A, Giezendanner S, Maier S, Leuppi-Taegtmeyer A, Arnet I, Hersberger KE, Leuppi JD. Gregoriano C, et al. Among authors: giezendanner s. Respir Res. 2019 Dec 3;20(1):273. doi: 10.1186/s12931-019-1219-3. Respir Res. 2019. PMID: 31796013 Free PMC article. Clinical Trial.
Cardiovascular risk stratification in primary care patients with arterial hypertension: Results from the Swiss Hypertension Cohort Study (HccH).
Handschin A, Brighenti-Zogg S, Mundwiler J, Giezendanner S, Gregoriano C, Martina B, Tschudi P, Leuppi JD, Zeller A, Dieterle T. Handschin A, et al. Among authors: giezendanner s. Eur J Prev Cardiol. 2019 Nov;26(17):1843-1851. doi: 10.1177/2047487319856732. Epub 2019 Jun 12. Eur J Prev Cardiol. 2019. PMID: 31189378
Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers.
Huebner ST, Henny S, Giezendanner S, Brack T, Brutsche M, Chhajed P, Clarenbach C, Dieterle T, Egli A, Frey M, Heijnen I, Irani S, Sievi NA, Thurnheer R, Trendelenburg M, Kohler M, Leuppi-Taegtmeyer AB, Leuppi JD. Huebner ST, et al. Among authors: giezendanner s. Respiration. 2022;101(5):441-454. doi: 10.1159/000520196. Epub 2021 Dec 23. Respiration. 2022. PMID: 34942619 Free PMC article.
50 results